TA, F. (2023). Editorial: Intracoronary Brachytherapy for In-Stent Restenosis: Not Bad in the Sprint, But Fails in the Marathon. Cardiovascular revascularization medicine : including molecular interventions, 54, 5. https://doi.org/10.1016/j.carrev.2023.05.019
Chicago Style (17th ed.) CitationTA, Fischell. "Editorial: Intracoronary Brachytherapy for In-Stent Restenosis: Not Bad in the Sprint, But Fails in the Marathon." Cardiovascular Revascularization Medicine : Including Molecular Interventions 54 (2023): 5. https://doi.org/10.1016/j.carrev.2023.05.019.
MLA (9th ed.) CitationTA, Fischell. "Editorial: Intracoronary Brachytherapy for In-Stent Restenosis: Not Bad in the Sprint, But Fails in the Marathon." Cardiovascular Revascularization Medicine : Including Molecular Interventions, vol. 54, 2023, p. 5, https://doi.org/10.1016/j.carrev.2023.05.019.